MedTrace Logo

Longitudinal Characterization of Respiratory Tract Exacerbations and Treatment Responses in Primary Ciliary Dyskinesia

NCT05161858 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-12-10

No results posted yet for this study

Summary

The overall objective of this longitudinal, observational study is to provide information needed to inform the design of future interventional trials of respiratory exacerbation prevention and treatment in children and adults with primary ciliary dyskinesia (PCD).

Conditions

  • Primary Ciliary Dyskinesia
  • Kartagener Syndrome

Sponsors & Collaborators

  • Washington University School of Medicine

    collaborator OTHER

  • Children's Hospital Colorado

    collaborator OTHER

  • Stanford University

    collaborator OTHER

  • Seattle Children's Hospital

    collaborator OTHER

  • The Hospital for Sick Children

    collaborator OTHER

  • McGill University

    collaborator OTHER

  • Children's Hospital Medical Center, Cincinnati

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Margaret Rosenfeld, MD · Seattle Children's Hospital

  • Scott Sagel, MD, PhD · Children's Hospital Colorado

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-29
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05161858 on ClinicalTrials.gov